WILLIAM WONG to Phenylurea Compounds
This is a "connection" page, showing publications WILLIAM WONG has written about Phenylurea Compounds.
Connection Strength
0.158
-
Lenvatinib Versus Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Cost-Utility Analysis. Oncologist. 2020 03; 25(3):e512-e519.
Score: 0.158
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.